Celldex Therapeutics Inc (CLDX): $CLDX Celldex Remains A Premier Immunoth...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	26
Posts	1372
Boards Moderated	0
Alias Born	01/18/2011

maytepper

Re: None

Wednesday, 11/05/2014 10:14:43 AM

Wednesday, November 05, 2014 10:14:43 AM

$CLDX Celldex Remains A Premier Immunotherapy Player To Watch Going Into 2015, Says Roth Capital http://www.smarteranalyst.com/2014/11/05/celldex-remains-a-premier-immunotherapy-player-to-watch-going-into-2015-says-roth-capital/

Keep Last Read

Replies (1) Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent CLDX News

Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/14/2024 09:34:12 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/14/2024 09:12:27 PM
Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 06/14/2024 08:02:10 PM
Form 8-K - Current report • Edgar (US Regulatory) • 06/14/2024 12:00:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 08:05:23 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:02:57 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/11/2024 08:01:54 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/07/2024 09:23:29 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/07/2024 08:57:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/07/2024 08:05:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:06:42 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:05:45 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/05/2024 08:04:58 PM
Celldex Therapeutics to Present at Jefferies Healthcare Conference • GlobeNewswire Inc. • 06/04/2024 08:01:00 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 09:51:13 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 06/03/2024 09:14:16 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:06:26 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:05:49 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:04:55 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:04:08 PM
Celldex Therapeutics Presents Data Demonstrating Profound Improvements in Angioedema in Barzolvolimab Phase 2 Study in Chronic Spontaneous Urticaria at EAACI 2024 • GlobeNewswire Inc. • 06/02/2024 01:01:00 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/30/2024 10:05:37 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/30/2024 10:01:55 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/30/2024 09:47:21 PM
Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 05/30/2024 07:20:24 PM

More CLDX News

InvestorsHub NewsWire

ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM

Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM

Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM

HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM

Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM

Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover